Does IDURSULFASE Cause Infusion site extravasation? 41 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Infusion site extravasation have been filed in association with IDURSULFASE (ELAPRASE). This represents 1.3% of all adverse event reports for IDURSULFASE.
41
Reports of Infusion site extravasation with IDURSULFASE
1.3%
of all IDURSULFASE reports
1
Deaths
20
Hospitalizations
How Dangerous Is Infusion site extravasation From IDURSULFASE?
Of the 41 reports, 1 (2.4%) resulted in death, 20 (48.8%) required hospitalization, and 1 (2.4%) were considered life-threatening.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IDURSULFASE. However, 41 reports have been filed with the FAERS database.
What Other Side Effects Does IDURSULFASE Cause?
Pyrexia (524)
Product dose omission issue (450)
Inappropriate schedule of product administration (371)
Cough (263)
Infusion related reaction (241)
Pneumonia (232)
Death (222)
Dyspnoea (202)
Influenza (200)
Covid-19 (197)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which IDURSULFASE Alternatives Have Lower Infusion site extravasation Risk?
IDURSULFASE vs IFOSFAMIDE
IDURSULFASE vs IGURATIMOD
IDURSULFASE vs ILOPERIDONE
IDURSULFASE vs ILOPROST
IDURSULFASE vs IMATINIB